Dr. Srinath Pashikanti

College of Pharmacy

Idaho State University, USA

Assistant Professor



2012-2014 Ph.D., Medicinal Chemistry, School of Pharmacy, The University of Kansas, USA

2007-2011 M.S., Medicinal Chemistry, The University of Kansas, USA

2005-2007 M.S., Chemistry, South Dakota State University, USA

Publications (selected)

  1. Foster, A., Li, Y., Runyan, S., Dinh, T., Venadas, S., Chen, J., Pashikanti, S., Datta, A., Ehring, G., Staubli, U., Activity of the enantiomers of erythro-3-hydroxyaspartate at glutamate transporters and NMDA receptors, Journal of Neurochemisry, 2016, 136, 692 – 697.
  2. Pashikanti, S., Sibley, C., Nguyen, M.K., Santos, W.L., Regio- and Stereoselective Copper (II)-Catalyzed Hydrosilylation of Activated Allenes in Water: Access to Vinylsilanes, Organic Letters, 2016, 18, 2443-2446.
  3. Pashikanti, S., Sibley, C., Nguyen, M. K., Santos, W.L., Copper (II)-Catalyzed (E)-Selective Hydrosilylation of Allenes, Synfacts, 2016, 12, 0836-0836.
  4. Pashikanti, S., Boissonneault, G.A., Cervantes, D.L., Ex vivo detection of histone H1 modified with advanced glycation end products, Free Radical Biology and Medicine, 2011, 50, 1410 – 1416.
  5. Pashikanti, S., de Alba, D.R., Boissonneault, G.A., Cervantes, D.L., Rutin Metabolites: Novel Inhibitors of Non-oxidative Advanced Glycation End Products, Free Radical Biology and Medicine, 2010, 48, 656.
  6. Cervantes, D.L., Pashikanti, S., Rutin derivatives as potent AGE inhibitors and its relevance in diabetes complications, FASEB J., 2007, 21: 646.1.